← Eichor
Study identifier: NCT04524637 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

The Utility of Thromboelastography in Traumatic Brain Injury

Condition: Traumatic Brain Injury · Coagulation Disorder  ·  Sponsor: Shanghai 6th People's Hospital

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Hemocoagulation disorder is recognized to have crucial effects on hemorrhagic or ischemic diseases. Coagulation-related damages secondary to traumatic brain injury are common and severe secondary insults of head trauma and often leads to a poor prognosis. In this study, we sought to assess if posttraumatic hemocoagulation disorders determined using thromboelastography are associated with coagulation-related damages secondary to traumatic brain injury, and evaluate their influence on outcome among patients with head trauma. Based on above results, prediction models or risk scoring systems will be further developed and validated to predict coagulation-related damages secondary to traumatic brain injury.

This description comes directly from the study's public registry record.

Talk to the study team

Hao Chen, M.D., Ph.D.  ·  86-21-64369181  ·  chenhao_316@aliyun.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Sixth People's HospitalShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04524637